Early phase drug development: Assessing, predicting and formulating with delivery in mind
Development of new therapeutics demands substantial investment of time and capital, frequently with low chances of success. As a result, there is huge pressure to deliver reduced timelines and realise drug development programs. Scientists involved in development must balance opportunities to mitigate risk, and increase efficiency whilst maintaining quality. At Almac, we understand that developing therapeutics with a focus on delivery is fundamental to achieving success both in developmental phases and in the final product.
What you will learn:
- Early Drug Development Challenges
- Understanding Drug Molecules
- Developability Assessment
- Formulating for Success
- Assessing Formulations
Almac API, Chemical Development, Analytical & Solid State Services
Almac Sciences provides integrated services from development to commercial scale of advanced intermediates and Active Pharmaceutical Ingredients (API).
We provide a range of services for small molecules (including highly potent) and peptides. We have a proven track record of saving time and cost through the integration of our services and application of innovative biocatalysis and technology solutions.
We offer a full suite of analytical testing for a range of different product types including small molecules, peptides, biologics, conjugates, potent and controlled substances.
Our vast pool of scientific knowledge can help to overcome the analytical challenges that typically arise during drug development.